NCT00203086
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
Not specified
Clinical trial condition
Multiple Sclerosis, Relapsing-Remitting
Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.
455 public trials
46 recruiting studies
Multiple Sclerosis, Relapsing-Remitting trial results
Completed
Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
NCT00030966
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- University of Alabama-Birmingham, Department of Neurology Birmingham, Alabama, United States
- Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States
- University of Arkansas For Medical Sciences Little Rock, Arkansas, United States
- University of California - Irvine Irvine, California, United States
NCT00097760
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
Not specified
NCT00492570
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cognition Disorders, +10 more
- Locations
-
Not specified
NCT00859482
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
Not specified
NCT00594087
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +14 more
- Locations
-
- University of Vermont Burlington, Vermont, United States
NCT00099502
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Birmingham, Alabama, United States
- Cullman, Alabama, United States
- Phoenix, Arizona, United States
- Tucson, Arizona, United States
Completed
AVONEX® Combination Trial - "ACT"
NCT00112034
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- MS Academic Coordinating Center Cleveland, Ohio, United States
NCT00382629
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
Not specified
NCT00492466
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Coordinating Research Site Turku, Finland